Cargando…

Effects and mechanism of dexmedetomidine on neuronal cell injury induced by hypoxia-ischemia

BACKGROUND: The present study aims to investigate the protective effects of dexmedetomidine (DMED) on hypoxia ischemia injury induced by oxygen and glucose deprivation (OGD) in PC12 and primary neuronal cells. METHODS: PC12 cells exposed to OGD was used to establish ischemia model. The OGD-induced c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Ya-Jun, Wang, Duan-Yu, Yang, Yong-Jian, Lei, Wei-Fu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5577810/ https://www.ncbi.nlm.nih.gov/pubmed/28854873 http://dx.doi.org/10.1186/s12871-017-0413-4

Ejemplares similares

Dexmedetomidine inhibits neuronal apoptosis by inducing Sigma-1 receptor signaling in cerebral ischemia-reperfusion injury
por: Zhai, Meili, et al.
Publicado: (2019)

The activation of SIRT3 by dexmedetomidine mitigates limb ischemia-reperfusion–induced lung injury
por: Wang, Lei, et al.
Publicado: (2022)

Dexmedetomidine protects cardiomyocytes against hypoxia/reoxygenation injury via multiple mechanisms
por: Cai, Shunv, et al.
Publicado: (2021)

Dexmedetomidine attenuates hypoxia/reoxygenation injury in primary neonatal rat cardiomyocytes
por: Peng, Ke, et al.
Publicado: (2017)

Renoprotective effects of dexmedetomidine against ischemia-reperfusion injury in streptozotocin-induced diabetic rats
por: Kim, Seung Hyun, et al.
Publicado: (2018)

Dexmedetomidine attenuates neuronal injury induced by cerebral ischemia-reperfusion by regulating miR-199a
por: Zhu, Yulin, et al.
Publicado: (2021)

Effects of dexmedetomidine on renal microcirculation in ischemia/reperfusion-induced acute kidney injury in rats
por: Yang, Szu-Jen, et al.
Publicado: (2021)

Effect of dexmedetomidine on lung ischemia-reperfusion injury
por: JIANG, LILI, et al.
Publicado: (2014)

The Application and Analytical Pathway of Dexmedetomidine in Ischemia/Reperfusion Injury
por: Tang, Ying, et al.
Publicado: (2019)

Dexmedetomidine Leads to the Mitigation of Myocardial Ischemia/Reperfusion-Induced Acute Lung Injury in Diabetic Rats Via Modulation of Hypoxia-Inducible Factor-1α
por: Chen, Siyu, et al.
Publicado: (2022)

Dexmedetomidine Protects against Ischemia and Reperfusion-Induced Kidney Injury in Rats
por: Bao, Naren, et al.
Publicado: (2020)

Effect of dexmedetomidine pretreatment on lung injury following intestinal ischemia-reperfusion
por: SHEN, JINMEI, et al.
Publicado: (2013)

Pretreatment with Resveratrol Prevents Neuronal Injury and Cognitive Deficits Induced by Perinatal Hypoxia-Ischemia in Rats
por: Arteaga, Olatz, et al.
Publicado: (2015)

Dexmedetomidine preconditioning ameliorates kidney ischemia-reperfusion injury
por: Lempiäinen, Juha, et al.
Publicado: (2014)

Dexmedetomidine preconditioning protects against lung injury induced by ischemia-reperfusion through inhibition of autophagy
por: Zhang, Wei, et al.
Publicado: (2017)

Dexmedetomidine Pretreatment Protects Against Myocardial Ischemia/Reperfusion Injury by Activating STAT3 Signaling
por: Chen, Zhao-Rong, et al.
Publicado: (2023)

Dexmedetomidine Mediates Neuroglobin Up-Regulation and Alleviates the Hypoxia/Reoxygenation Injury by Inhibiting Neuronal Apoptosis in Developing Rats
por: Gao, Yan, et al.
Publicado: (2020)

Dexmedetomidine Attenuates Ischemia/Reperfusion-Induced Myocardial Inflammation and Apoptosis Through Inhibiting Endoplasmic Reticulum Stress Signaling
por: Yang, Yu-fan, et al.
Publicado: (2021)

Dexmedetomidine provides renoprotection against ischemia-reperfusion injury in mice
por: Gu, Jianteng, et al.
Publicado: (2011)

Evolving spectrum of dexmedetomidine preconditioning for Ischemia–reperfusion injury amelioration
por: Kohli, Jasvinder K., et al.
Publicado: (2020)

Dexmedetomidine ameliorates ischemia-induced nerve injury by up-regulating Sox11 expression
por: Wang, Qiong, et al.
Publicado: (2023)

Dexmedetomidine enhances hypoxia-induced cancer cell progression
por: Chen, Hua Yan, et al.
Publicado: (2019)

Amelioration of myocardial ischemia/reperfusion injury in diabetes: A narrative review of the mechanisms and clinical applications of dexmedetomidine
por: Sun, Meng, et al.
Publicado: (2022)

The Hypoxia-Adenosine Link during Myocardial Ischemia—Reperfusion Injury
por: Ruan, Wei, et al.
Publicado: (2022)

Dexmedetomidine reduces propofol-induced hippocampal neuron injury by modulating the miR-377-5p/Arc pathway
por: Chen, Zong, et al.
Publicado: (2022)

Dexmedetomidine attenuates traumatic brain injury: action pathway and mechanisms
por: Wang, Dong, et al.
Publicado: (2018)

Hypoxia-preconditioned mesenchymal stem cells ameliorate ischemia/reperfusion-induced lung injury
por: Liu, Yung-Yang, et al.
Publicado: (2017)

Dexmedetomidine Protects Mouse Brain from Ischemia-Reperfusion Injury via Inhibiting Neuronal Autophagy through Up-Regulating HIF-1α
por: Luo, Cong, et al.
Publicado: (2017)

Dexmedetomidine postconditioning suppresses myocardial ischemia/reperfusion injury by activating the SIRT1/mTOR axis
por: Zhang, Xiong, et al.
Publicado: (2020)

The Protective Effect of Dexmedetomidine Against Ischemia-Reperfusion Injury after Hepatectomy: A Meta-Analysis of Randomized Controlled Trials
por: Huang, Ya-Qun, et al.
Publicado: (2021)

The preventive effects of dexmedetomidine against intestinal ischemia-reperfusion injury in Wistar rats
por: Zhang, Xue-kang, et al.
Publicado: (2015)

The effect of dexmedetomidine on gastric ischemia reperfusion injury in rats. Biochemical and histopathological evaluation
por: Kuyrukluyildiz, Ufuk, et al.
Publicado: (2021)

Irisin Contributes to the Hepatoprotection of Dexmedetomidine during Intestinal Ischemia/Reperfusion
por: Fan, Xin, et al.
Publicado: (2019)

Hypoxia inducible factor 1α promotes interleukin-1 receptor antagonist expression during hepatic ischemia-reperfusion injury
por: Wang, Zhao-Yang, et al.
Publicado: (2022)

Hypoxia-inducible factor prolyl hydroxylase inhibitor roxadustat (FG-4592) protects against renal ischemia/reperfusion injury by inhibiting inflammation
por: Miao, A-Feng, et al.
Publicado: (2021)

Dexmedetomidine attenuates cerebral ischemia/reperfusion injury in neonatal rats by inhibiting TLR4 signaling
por: Cheng, Jiangxia, et al.
Publicado: (2018)

Effect of intraoperative dexmedetomidine on hepatic ischemia-reperfusion injury in pediatric living-related liver transplantation: A propensity score matching analysis
por: Zhang, Liang, et al.
Publicado: (2022)

Protective effects of dexmedetomidine on hypoxia/reoxygenation injury in cardiomyocytes by regulating the CHOP signaling pathway
por: Shi, Xiaoqiao, et al.
Publicado: (2020)

Dexmedetomidine attenuates spinal cord ischemia–reperfusion injury through both anti-inflammation and anti-apoptosis mechanisms in rabbits
por: Sun, Zhixiang, et al.
Publicado: (2018)

Curcumin attenuates hypoxia/reoxygenation-induced myocardial injury
por: Wei, Wenjuan, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_lfk56doch70aolqb1big6ppg6a